New insights into the neurobiology, diagnosis, and treatment of mood disorders

Autor Zarate, Carlos A.
Vydáno 2013

What Should be Done When Elderly Patients with Major Depression Have Failed to Respond to All Treatments?

Autor Zarate, Carlos A.
Vydáno v Am J Geriatr Psychiatry (2017)

Ketamine: a new chapter in antidepressant development

Autor Zarate, Carlos A.
Vydáno v Braz J Psychiatry (2020)

Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder

Autor Zarate, Carlos A.
Vydáno v Can J Psychiatry (2021)

Magnetic Resonance Spectroscopy Studies of the Glutamatergic System in Mood Disorders: A Pathway to Diagnosis, Novel Therapeutics, and Personalized Medicine?

Autor Salvadore, Giacomo, Zarate, Carlos A.
Vydáno 2010

Depression in the Primary Care Setting

Autor Park, Lawrence T., Zarate, Carlos A.
Vydáno v N Engl J Med (2019)

Depression in the Primary Care Setting

Autor Park, Lawrence T., Zarate, Carlos A.
Vydáno v N Engl J Med (2019)

The Role of AMPA Receptor Modulation in the Treatment of Neuropsychiatric Diseases

Autor Zarate, Carlos A., Manji, Husseini K.
Vydáno 2008

A Review of the Preclinical and Clinical Evidence for Protein Kinase C as a Target for Drug Development for Bipolar Disorder

Autor DiazGranados, Nancy, Zarate, Carlos A.
Vydáno 2008

Putative Drugs and Targets for Bipolar Disorder

Autor Zarate, Carlos A., Manji, Husseini K.
Vydáno 2008

Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder

Autor Zarate, Carlos A., Manji, Husseini K.
Vydáno 2009

Proof of Concept Trials in Bipolar Disorder and Major Depressive Disorder: A Translational Perspective in the Search for Improved Treatments

Autor Machado-Vieira, Rodrigo, Zarate, Carlos A.
Vydáno 2011

Current Status of Ketamine and Related Compounds for Depression

Autor Mathews, Daniel C., Zarate, Carlos A.
Vydáno 2013

Ketamine, Sleep, and Depression: Current Status and New Questions

Autor Duncan, Wallace C., Zarate, Carlos A.
Vydáno 2013

Ketamine for depression: evidence, challenges and promise

Autor Zarate, Carlos A, Niciu, Mark J
Vydáno v World Psychiatry (2015)

Pulsed Intravenous Administration of Scopolamine Produces Rapid Antidepressant Effects and Modest Side Effects

Autor Furey, Maura L., Zarate, Carlos A.
Vydáno v J Clin Psychiatry (2013)

Potential Pathways Involved in the Rapid Antidepressant Effects of Nitrous Oxide

Autor Zarate, Carlos A., Machado-Vieira, Rodrigo
Vydáno v Biol Psychiatry (2015)

GSK-3: a key regulatory target for ketamine’s rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput

Autor Zarate, Carlos A, Machado-Vieira, Rodrigo
Vydáno v Bipolar Disord (2016)

Preventing Suicide: A Multicausal Model Requires Multimodal Research and Intervention

Autor Ballard, Elizabeth D., Zarate, Carlos A.
Vydáno v Bipolar Disord (2018)

Using Neuroimaging to Decipher the Mechanism of Action of Ketamine: A Pathway to Novel Therapeutics?

Autor Nugent, Allison C., Zarate, Carlos A.
Vydáno v Biol Psychiatry Cogn Neurosci Neuroimaging (2017)